Author:
Murphy M. J.,Duncan A.,Vallance B. D.,Packard C. J.,O'Reilly D. S.
Reference8 articles.
1. Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis;Nestel, P.J.; Billington, T.;Atherosclerosis,1981
2. Increase in plasma cholesteryl ester transfer protein during probucol treatment;McPherson, R.; Hogue, M.; Milne, R.W.; Tall, A.R.; Marcel, Y.L.;Arterioscler Thromb,1991
3. Effect of probucol on the activity of postheparin plasma lipoprotein lipase and hepatic lipase;Miettinen, T.A.; Huttunen, J.W.; Kuusi, T.;Clin Chim Acta,1981
4. Effect of probucol on the composition of lipoproteins and on VLDL apolipoprotein B turnover;Lock, D.R.; Kuisk, I.; Gonen, B.; Patsch, W.; Schonfeld, G.;Atherosclerosis,1983
5. Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters;Vessby, E.; Lithell, H.; Hellsing, K.;Atherosclerosis,1980
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current Status of Familial LCAT Deficiency in Japan;Journal of Atherosclerosis and Thrombosis;2021
2. Iatrogenic Severe Depression of High-Density Lipoprotein Cholesterol;The Journal of Clinical Pharmacology;2009-07
3. Severe acquired (secondary) high-density lipoprotein deficiency;Journal of Clinical Lipidology;2007-03
4. Fibrates and HDL Cholesterol;Annals of Clinical Biochemistry: International Journal of Laboratory Medicine;1997-01
5. Fibrate monotherapy and profound hypoalphalipoproteinaemia.;Postgraduate Medical Journal;1996-03-01